Terms: = Colorectal cancer AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Prognosis
31 results:
1. Site specific genetic differences in colorectal cancer via Next-Generation-Sequencing using a multigene panel.
Rencuzogullari A; Bisgin A; Erdogan KE; Gumus S; Yalav O; Boga I; Sonmezler O; Eray IC
Ann Ital Chir; 2023; 94():605-611. PubMed ID: 38131395
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
[TBL] [Abstract] [Full Text] [Related]
3. MicroRNA 483-3p overexpression unleashes invasive growth of metastatic colorectal cancer via NDRG1 downregulation and ensuing activation of the erbb3/AKT axis.
Candiello E; Reato G; Verginelli F; Gambardella G; D Ambrosio A; Calandra N; Orzan F; Iuliano A; Albano R; Sassi F; Luraghi P; Comoglio PM; Bertotti A; Trusolino L; Boccaccio C
Mol Oncol; 2023 Jul; 17(7):1280-1301. PubMed ID: 36862005
[TBL] [Abstract] [Full Text] [Related]
4. Effect of Cetuximab-Conjugated Gold Nanoparticles on the Cytotoxicity and Phenotypic Evolution of colorectal cancer Cells.
El Hallal R; Lyu N; Wang Y
Molecules; 2021 Jan; 26(3):. PubMed ID: 33499047
[TBL] [Abstract] [Full Text] [Related]
5. HER4 promotes the progression of colorectal cancer by promoting epithelial‑mesenchymal transition.
Jia X; Wang H; Li Z; Yan J; Guo Y; Zhao W; Gao L; Wang B; Jia Y
Mol Med Rep; 2020 Apr; 21(4):1779-1788. PubMed ID: 32319604
[TBL] [Abstract] [Full Text] [Related]
6. HER2-her3 Heterodimer Quantification by FRET-FLIM and Patient Subclass Analysis of the COIN colorectal Trial.
Barber PR; Weitsman G; Lawler K; Barrett JE; Rowley M; Rodriguez-Justo M; Fisher D; Gao F; Tullis IDC; Deng J; Brown L; Kaplan R; Hochhauser D; Adams R; Maughan TS; Vojnovic B; Coolen ACC; Ng T
J Natl Cancer Inst; 2020 Sep; 112(9):944-954. PubMed ID: 31851321
[TBL] [Abstract] [Full Text] [Related]
7. Exome sequencing of 22 genes using tissue from patients with biliary tract cancer.
Høgdall D; Larsen OF; Linnemann D; Svenstrup Poulsen T; Høgdall EV
APMIS; 2020 Jan; 128(1):3-9. PubMed ID: 31628675
[TBL] [Abstract] [Full Text] [Related]
8. Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung.
Djureinovic D; Pontén V; Landelius P; Al Sayegh S; Kappert K; Kamali-Moghaddam M; Micke P; Ståhle E
BMC Cancer; 2019 Jul; 19(1):741. PubMed ID: 31357969
[TBL] [Abstract] [Full Text] [Related]
9. Histologic features and genomic alterations of primary colorectal adenocarcinoma predict growth patterns of liver metastasis.
Wu JB; Sarmiento AL; Fiset PO; Lazaris A; Metrakos P; Petrillo S; Gao ZH
World J Gastroenterol; 2019 Jul; 25(26):3408-3425. PubMed ID: 31341365
[TBL] [Abstract] [Full Text] [Related]
10. Association between the overexpression of her3 and clinical pathology and prognosis of colorectal cancer: A meta-analysis.
Yan Q; Guo K; Feng G; Shan F; Sun L; Zhang K; Shen F; Shen M; Ruan S
Medicine (Baltimore); 2018 Sep; 97(37):e12317. PubMed ID: 30212974
[TBL] [Abstract] [Full Text] [Related]
11. Lapatinib.
Voigtlaender M; Schneider-Merck T; Trepel M
Recent Results Cancer Res; 2018; 211():19-44. PubMed ID: 30069757
[TBL] [Abstract] [Full Text] [Related]
12. Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor prognosis in colorectal cancer.
Yun S; Kwak Y; Nam SK; Seo AN; Oh HK; Kim DW; Kang SB; Lee HS
Cancer Res Treat; 2018 Oct; 50(4):1351-1361. PubMed ID: 29361822
[TBL] [Abstract] [Full Text] [Related]
13. BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell lines.
Herr R; Halbach S; Heizmann M; Busch H; Boerries M; Brummer T
Oncogene; 2018 Mar; 37(12):1576-1593. PubMed ID: 29326440
[TBL] [Abstract] [Full Text] [Related]
14. HRG/HER2/her3 signaling promotes AhR-mediated Memo-1 expression and migration in colorectal cancer.
Bogoevska V; Wolters-Eisfeld G; Hofmann BT; El Gammal AT; Mercanoglu B; Gebauer F; Vashist YK; Bogoevski D; Perez D; Gagliani N; Izbicki JR; Bockhorn M; Güngör C
Oncogene; 2017 Apr; 36(17):2394-2404. PubMed ID: 27941874
[TBL] [Abstract] [Full Text] [Related]
15. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
[TBL] [Abstract] [Full Text] [Related]
16. her3 expression is correlated to distally located and low-grade colon cancer.
Lédel F; Stenstedt K; Hallström M; Ragnhammar P; Edler D
Acta Oncol; 2016 Jul; 55(7):875-80. PubMed ID: 26863446
[TBL] [Abstract] [Full Text] [Related]
17. Immuno-PET Imaging of her3 in a Model in which her3 Signaling Plays a Critical Role.
Yuan Q; Furukawa T; Tashiro T; Okita K; Jin ZH; Aung W; Sugyo A; Nagatsu K; Endo H; Tsuji AB; Zhang MR; Masuko T; Inoue M; Fujibayashi Y; Saga T
PLoS One; 2015; 10(11):e0143076. PubMed ID: 26571416
[TBL] [Abstract] [Full Text] [Related]
18. Pyrosequencing-Based Assays for Rapid Detection of HER2 and her3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting her3 in Retroperitoneal Leiomyosarcoma.
González-Alonso P; Chamizo C; Moreno V; Madoz-Gúrpide J; Carvajal N; Daoud L; Zazo S; Martín-Aparicio E; Cristóbal I; Rincón R; García-Foncillas J; Rojo F
Int J Mol Sci; 2015 Aug; 16(8):19447-57. PubMed ID: 26287187
[TBL] [Abstract] [Full Text] [Related]
19. HER family receptor expression and prognosis in pancreatic cancer.
Bittoni A; Mandolesi A; Andrikou K; Santoni M; Alfonsi S; Lanese A; Loretelli C; Pellei C; Piva F; Scarpelli M; Cascinu S
Int J Biol Markers; 2015 Jul; 30(3):e327-32. PubMed ID: 26109364
[TBL] [Abstract] [Full Text] [Related]
20. [Accumulation of p53 protein and overexpression of the her3 receptor in colorectal cancer].
Amsaguine S; El Mhaia S; Drissi H; Amer C; Ahallat M; El Amrani N; Radallah D
Ann Biol Clin (Paris); 2015; 73(2):158-64. PubMed ID: 25847737
[TBL] [Abstract] [Full Text] [Related]
[Next]
